CompletedInterventionalPhase 3Last updated Oct 12, 2015

Effects of Cisatracurium on Sccinylcholine-induced Fasciculations

Effects of Pretreatment With Different Doses of Cisatracurium on Succinylcholine-induced Fasciculations

Overview

ClinicalTrials.gov ID: NCT02502032
Lead Sponsor: Zhuan ZhangOTHER
Brief Summary: To investigate the effects of different doses of cisatracurium pretreatment on succinylcholine-induced fasciculations.
Study Type: Interventional

Status

Study Record Dates

NCT02481193Completed

Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia

NCT05760976Unknown status

Median Effective Dose of Cisatracurium for the Prevention of Fasciculation Caused by the Injection of Succinylcholine

NCT04921735Completed

An Observational Study of Cisatracurium 0.15 mg/kg in Young and Elderly (≥ 80 Years) Patients.

NCT04581395Completed

The Effect of Pretreatment With Roc on Succinylcholine Myalgias

NCT03337373Completed

The Study of Pharmacokinetics and Pharmacodynamics of Cisatracurium

NCT01785446Unknown status

Study of Cisatracurium and Sufentanil Consumption Using a Closed Loop Computer Control Infusion System